Endoscopic ultrasound (EUS) is a minimally invasive technique used to diagnose diseases of the gastrointestinal system and other surrounding organs and tissues. Endoscopic ultrasound combines the use of a thin, flexible tube (endoscope) that is inserted into the gastrointestinal tract and a device that uses sound waves to create images (ultrasound). Surrounding organs and tissue, including the lungs, pancreas, gallbladder, liver, and lymph nodes, are also clearly visible on the high-resolution images created by the high-frequency sound waves.
The global Endoscopic Ultrasound (EUS) Market size generated $1.2 billion in 2021, and is expected to reach $2.2 billion by 2031, witnessing a CAGR of 6.1% from 2022 to 2031. The report offers an in-depth analysis of changing market trends, top segments, value chain, and competitive landscape. This report provides detailed information to assist market players, stakeholders, investors, and startups in devising strategies for gaining sustainable growth and availing competitive advantage in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/18050
Covid-19 Scenario:
- The Covid-19 pandemic has had a negative impact on the growth of the Endoscopic Ultrasound (EUS) market, due to the delay in non-urgent procedures with an increased focus on the treatment of patients suffering from Covid-19 infection. Many treatments that did not require urgent care have been postponed to treat patients infected with Covid.
- The COVID-19 pandemic has presented challenges for the pharmaceutical industry as there have been disruptions in research and development activities, including endoscopic ultrasound (EUS). This, in turn, has impacted the overall market revenue. • However, the demand for endoscopic ultrasound is expected to increase after the pandemic as regular visits to hospitals and clinics begin with the start of vaccinations and the possibility of cross-contamination is also reduced.
- • R&D activities have been impacted during the pandemic due to disruptions in the operations of research and healthcare institutions. The pace of development of technologically advanced devices has slowed down. However, it will gain traction after the pandemic.
The research provides detailed segmentation of the global endoscopic ultrasound (EUS) market based on product, application, end user, and region. The report offers a detailed analysis of segments and sub-segments to determine the highest revenue-generating and highest-growing segments for market players and investors. Market size and forecasts are provided for segments and their sub-segments in the report to outline the steps taken for achieving the sustainable growth.
Speak to our Analyst :
https://www.alliedmarketresearch.com/connect-to-analyst/18050
Based on product, the endoscopes segment accounted for the highest share in 2021, contributing to more than one-fourth of the total share, and is estimated to maintain its leadership status during the forecast period. However, the needles segment is expected to manifest the highest CAGR of 6.8% from 2022 to 2031. The report also analyzes the segments including ultrasound probes, ultrasonic processors, imaging system, and accessories.
Based on application, the pancreatic conditions segment held the highest share in 2021, accounting for nearly more than half of the global endoscopic ultrasound (EUS) market, and is estimated to maintain its lead position during the forecast period. However, the oncology segment is expected to manifest the highest CAGR of 6.8% from 2022 to 2031.
Based on end user, the hospitals segment contributed to the highest share in 2021, holding nearly three-fifths of the total market share, and is expected to maintain its dominance in terms of revenue by 2031. However, the ambulatory surgery centers and clinics segment is projected to register the highest CAGR of 6.3% during the forecast period.
Based on region, North America held the highest share in 2021, contributing to more than one-third of the global endoscopic ultrasound market, and is expected to continue its dominance by 2031. However, Asia-Pacific is projected to grow at the fastest CAGR of 7.1% during the forecast period. The research also analyzes regions including Europe and LAMEA.
The research provides detailed analysis of leading players of the global endoscopic ultrasound (EUS) market.
Key players analyzed in the research include-
Boston Scientific Corporation,
Cook Medical,
CONMED Corporation,
Medtronic, Inc.,
Limaca Medical,
Pentax Medical,
Olympus Medical,
Sonoscape Medical Corp.,
Smith & Nephew plc, and Stryker Corporation.
Read More- https://www.alliedmarketresearch.com/press-release/endoscopic-ultrasound-eus-market.html